Stay updated on Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial
Sign up to get notified when there's something new on the Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial page.

Latest updates to the Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial page
- Check4 days agoChange DetectedRecruitment status updated to no longer looking for participants, indicating termination of enrollment. The record version was updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.5%

- Check12 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the prior revision v3.5.4 was removed from the history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe Record History now shows a new page revision (v3.5.4) replacing the previous revision (v3.5.3). This is a routine revision-tracking update and does not alter study data or visible page content.SummaryDifference0.1%

- Check55 days agoChange DetectedA minor webpage revision/version indicator changed from v3.5.2 to v3.5.3 for the ClinicalTrials.gov record history interface.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision entry v3.5.0 was added to the record history, and revision v3.4.3 was removed. This reflects an update to the historical record rather than changes to study content.SummaryDifference0.1%

Stay in the know with updates to Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial page.